Abstract
Anemia is a common cause of morbidity in the general population as it contributes to diminished quality of life and reduced physical and cognitive function. Inflammation is a major factor in the pathogenesis of anemia and thus, anemia is commonly observed in patients with acute and chronic infection, and other inflammatory conditions including cancer, arthritis, atherosclerosis, and diabetes. The mechanisms whereby inflammation may result in anemia are complex and incompletely understood although the recent discovery of the importance of a hepcidin production by the liver in response to inflammatory (among other) signals has improved our understanding as this cytokine is an important regulator of iron trafficking and utilization. Thus, although the anemia of inflammation remains difficult to reverse, optimism is high that we will soon have therapies directed at the mediators of anemia and these hold the promise of affording a major therapeutic advance.
Keywords: Anemia, inflammation, cytokines, hepcidin, iron homeaostasis, reticulendothelial system, tumor, chemotherapy, macrophages, erythropoiesis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: Inflammation and Anemia
Volume: 10 Issue: 4
Author(s): Mya Thein and William B. Ershler
Affiliation:
Keywords: Anemia, inflammation, cytokines, hepcidin, iron homeaostasis, reticulendothelial system, tumor, chemotherapy, macrophages, erythropoiesis
Abstract: Anemia is a common cause of morbidity in the general population as it contributes to diminished quality of life and reduced physical and cognitive function. Inflammation is a major factor in the pathogenesis of anemia and thus, anemia is commonly observed in patients with acute and chronic infection, and other inflammatory conditions including cancer, arthritis, atherosclerosis, and diabetes. The mechanisms whereby inflammation may result in anemia are complex and incompletely understood although the recent discovery of the importance of a hepcidin production by the liver in response to inflammatory (among other) signals has improved our understanding as this cytokine is an important regulator of iron trafficking and utilization. Thus, although the anemia of inflammation remains difficult to reverse, optimism is high that we will soon have therapies directed at the mediators of anemia and these hold the promise of affording a major therapeutic advance.
Export Options
About this article
Cite this article as:
Thein Mya and B. Ershler William, Inflammation and Anemia, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2011; 10 (4) . https://dx.doi.org/10.2174/187152311797928135
DOI https://dx.doi.org/10.2174/187152311797928135 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Advances in Protein and Peptide Drug Delivery: A Special Emphasis on Polymeric Nanoparticles
Protein & Peptide Letters Molecular Dissection of Renal Ischemia-Reperfusion: Oxidative Stress and Cellular Events
Current Medicinal Chemistry Neurologic and Cardiovascular Complications in Pediatric Life Threatening Imipramine Poisoning
Current Drug Safety Editorial: Pharmacological Therapy to Prevent Sudden Cardiac Death: Indications and Limitations in the Era of Devices
Mini-Reviews in Medicinal Chemistry Implementation of Cardiovascular Disease Prevention Guidelines into Clinical Practice: an Unmet Challenge?
Current Pharmaceutical Design Chemistry and Pharmacology of Angiotensin-Converting Enzyme Inhibitors
Current Pharmaceutical Design Modulation of Potassium Channels as a Therapeutic Approach
Current Pharmaceutical Design The Importance of Alkynyl Chain Presence for the Activity of Adenine Nucleosides/Nucleotides on Purinergic Receptors
Current Medicinal Chemistry Vaccine Development for Group A Streptococcus Infections and Associated Diseases
Current Drug Targets Engineered Nanoparticles for Improved Vasoactive Intestinal Peptide (VIP) Biomedical Applications
Recent Patents on Nanomedicine Molecular Mechanisms Involved in the Control of Neurohypophyseal Hormones Secretion
Current Pharmaceutical Design Toward a Discipline of Pharmacoepigenomics
Current Pharmacogenomics Advanced Drug Delivery of N-Acetylcarnosine (N-Acetyl-beta-alanyl-Lhistidine), Carcinine (Beta-alanylhistamine) and L-carnosine (Beta-alanyl- L-histidine) in Targeting Peptide Compounds as Pharmacological Chaperones for Use in Tissue Engineering, Human Disease Management and Therapy: From in vitro to the Clinic
Recent Patents on Drug Delivery & Formulation Genetically Modified Mice as Tools to Understand the Neurobiological Substrates of Depression
Current Pharmaceutical Design The Development of Medications for Alcohol-Use Disorders Targeting the GABAB Receptor System
Recent Patents on CNS Drug Discovery (Discontinued) Mood Disorders in Elderly Population: Neurostimulative Treatment Possibilities
Recent Patents on CNS Drug Discovery (Discontinued) Prevention of Endothelial Cell Injury by Activated Protein C: The Molecular Mechanism(s) and Therapeutic Implications
Current Vascular Pharmacology Reducing Perioperative Myocardial Infarction with Anesthetic Drugs and Techniques
Current Drug Targets Translational Pharmacology in Aging Men with Benign Prostatic Hyperplasia: Molecular and Clinical Approaches to Alpha1-Adrenoceptors
Current Aging Science Tumor Necrosis Factor: How to Make a Killer Molecule Tumor-Specific?
Current Cancer Drug Targets